zika
viru
new
emerg
mosquitoborn
viru
belong
flavivirida
famili
virus
famili
compris
genera
flaviviru
hepaciviru
pegiviru
pestiviru
zika
viru
belong
flaviviru
genu
antigen
phylogenet
relat
spondweni
viru
mani
import
human
pathogen
includ
genu
instanc
dengu
west
nile
yellow
fever
tickborn
enceph
japanes
enceph
murray
valley
enceph
st
loui
enceph
virus
virus
associ
rang
infect
asymptomat
selflimit
febril
infect
fatal
diseas
hemorrhag
shock
mening
enceph
flavivirida
famili
member
envelop
virus
singlestrand
rna
genom
posit
polar
contain
one
open
read
frame
orf
two
flank
noncod
region
end
genom
cap
without
poli
tail
polyprotein
code
orf
process
three
structur
protein
envelop
e
capsid
c
precursor
membran
prm
seven
nonstructur
protein
ssrna
held
within
icosahedr
capsid
shape
protein
block
nucleocapsid
surround
hostderiv
membran
contain
two
viral
glycoprotein
similar
replic
strategi
employ
member
flavivirida
famili
despit
signific
differ
tissu
tropism
transmiss
pathogenesi
present
time
effect
antivir
treatment
avail
zika
viru
infect
howev
consid
rapid
geograph
expans
zika
viru
sever
neurolog
complic
devast
effect
fetu
investig
underway
find
safe
potent
drug
therapi
approach
rang
repurpos
earlier
approv
drug
screen
test
silico
design
drug
antivir
candid
compris
agent
target
cellular
compon
addit
viral
one
step
zika
viru
life
cycl
host
cell
entri
releas
target
antivir
agent
order
block
viral
entri
cell
variou
strategi
use
one
hand
block
entri
receptor
bind
agent
nanchangmycin
previous
use
antibacteri
insecticid
agent
silico
design
propos
approach
includ
inhibit
endosom
fusion
use
compound
reduc
acid
endolysosom
vesicl
like
chloroquin
antimalaria
drug
disrupt
electrostat
interact
cell
viru
membran
use
squalamin
cation
chemic
rdrp
activ
outstand
target
antivir
drug
therefor
sever
nucleosid
analogu
investig
abil
inhibit
zika
viru
replic
despit
demonstr
efficaci
drug
cell
cultur
anim
model
unsuccess
clinic
trial
sofosbuvir
nucleotid
analog
inhibitor
rdrp
inhibitor
approv
fda
chronic
hcv
treatment
also
inhibit
zika
viru
replic
zika
viru
proteas
helicas
play
essenti
role
viru
replic
constitut
potenti
target
antivir
drug
zika
viru
helicas
similar
member
flavivirida
antivir
agent
target
helicas
could
also
use
zika
viru
likewis
berberin
previous
use
dengu
viru
show
high
bind
affin
zika
viru
proteas
well
despit
mani
studi
done
zika
antivir
treatment
far
fda
approv
categori
drug
found
safe
use
mother
fetus
first
larg
outbreak
zika
viru
infect
yap
island
feder
state
micronesia
sporad
case
serolog
evid
zika
viru
report
western
central
africa
southeast
asia
zika
viru
emerg
import
human
pathogen
increas
incid
case
syndrom
gb
report
larger
epidem
zika
viru
infect
french
polynesia
autochthon
transmiss
zika
viru
infect
occur
easter
island
chile
feb
jul
earli
sever
case
present
denguelik
syndrom
investig
brazil
nondengu
viru
nonchikungunya
viru
infect
zika
viru
detect
revers
transcript
polymeras
chain
reaction
rtpcr
assay
confirm
dna
sequenc
brazil
zika
viru
strain
share
common
ancestor
zika
viru
strain
circul
french
polynesia
jul
state
brazil
increas
number
case
half
report
symptom
consist
zika
viru
infect
jan
unusu
signific
increas
gb
report
el
salvador
emerg
committe
conven
directorgener
intern
health
regul
feb
final
announc
recent
cluster
microcephali
neurolog
disord
report
brazil
pheic
although
countri
eastern
mediterranean
region
report
import
zika
viru
diseas
autochthon
transmiss
howev
countri
region
follow
report
dengu
outbreak
recent
year
andor
presenc
compet
aed
mosquito
djibouti
egypt
oman
pakistan
saudi
arabia
somalia
sudan
yemen
countri
particularli
vulner
emerg
zika
viru
fragil
health
system
weak
diseas
surveil
system
inadequaci
respons
capac
suboptim
level
public
health
prepared
pakistan
mostatrisk
countri
region
primarili
due
larg
number
travel
america
dens
urban
popul
document
larg
epidem
dengu
favor
climat
condit
reproduct
aed
mosquito
iran
nation
committe
aedesborn
diseas
recommend
enhanc
surveil
updat
nation
guidelin
surveil
clinic
manag
suspect
case
especi
travel
return
atrisk
countri
sep
sampl
suspect
case
zika
viru
sent
nation
laboratori
aedesborn
diseas
shown
neg
prevent
aedesborn
diseas
need
comprehens
nation
strateg
action
plan
one
health
approach
close
collabor
commun
academ
public
health
author
global
map
zika
viru
infect
demonstr
fig
area
potenti
risk
zika
tabl
content
sourc
center
diseas
control
prevent
sep
updat
http
wwwnccdcgovtravelpageworldmapareaswithzika
studi
pathogenesi
zika
viru
shown
similar
pathogenesi
flaviviru
infect
follow
transmiss
mosquito
bite
zika
viru
infect
sever
differ
cell
type
includ
skin
keratinocyt
dermal
fibroblast
dendrit
cell
dc
vitro
studi
fibroblast
expos
zika
viru
shown
high
infect
rate
cell
h
infect
flow
cytometr
analys
dc
expos
viru
also
shown
dc
express
viral
antigen
around
h
infect
differ
cell
surfac
receptor
propos
mediat
zika
infect
permiss
cell
includ
dcsign
axl
molecul
fig
follow
cell
entri
zika
viru
induc
strong
interferon
respons
infect
cell
studi
zika
virusinfect
human
primari
fibroblast
shown
strong
upregul
interferonbeta
transcript
h
infect
milder
respons
report
interferonalpha
upregul
intracellular
pattern
recognit
receptor
prr
involv
sens
nonselfnucl
acid
seem
crucial
part
initi
immun
respons
viru
studi
zika
virusinfect
fibroblast
reveal
strong
induct
rigi
transcript
molecul
capabl
initi
signal
process
follow
detect
intracytoplasm
viral
rna
molecul
innat
immun
respons
follow
adapt
immun
event
includ
activ
cell
zika
virusinfect
dc
migrat
region
lymph
node
stimul
cell
prolifer
differenti
cytokin
product
product
infect
dermal
fibroblast
dendrit
cell
togeth
insuffici
control
infect
innat
adapt
immun
mechan
usual
lead
zika
viru
viremia
underli
nonspecif
clinic
symptom
might
last
day
pregnant
woman
matern
viremia
might
lead
fetal
viremia
well
known
viru
transmit
develop
nervou
system
follow
establish
fetal
viremia
circul
zika
viru
infect
fetal
monocyt
monocyt
carri
infect
develop
nervou
system
studi
fetal
brain
tissu
deriv
zika
virusinfect
mother
undergon
abort
shown
viral
particl
neural
cell
indic
viru
prolifer
insid
neural
cell
develop
brain
insid
cn
zika
viru
exert
direct
neurovirul
similar
flavivirus
also
evid
zika
viru
might
caus
indirect
neurovirul
activ
immun
mechan
includ
microgli
activ
macrophag
infiltr
inde
adult
zika
viru
might
etiolog
factor
acut
dissemin
encephalomyel
adem
immunemedi
diseas
cn
occur
subsequ
varieti
viral
nonvir
infect
whether
ademlik
process
might
affect
develop
brain
remain
open
question
depend
purpos
investig
laboratori
diagnosi
zika
viru
conduct
viru
isol
antigen
detect
viral
rna
detect
molecular
assay
antizika
viru
antibodi
detect
serolog
assay
first
isol
zika
viru
perform
intracerebr
mous
inocul
consid
refer
assay
arbovirus
isol
among
human
clinic
specimen
zika
viru
cultur
blood
urin
saliva
semen
antigen
detect
valuabl
assay
approv
zika
viru
infect
autopsi
tissu
use
immunohistochemistri
ihc
techniqu
zika
viru
antigen
detect
brain
placent
tissu
congenit
infect
newborn
microcephali
miscarriag
recent
new
assay
detect
zika
viru
antigen
includ
protein
identif
flow
cytometri
whole
blood
aptamerbas
elisa
assay
target
zika
viru
protein
protein
base
competit
elisa
rapid
test
develop
zika
viru
rna
detect
differ
type
bodi
fluid
blood
serum
plasma
urin
saliva
semen
breast
milk
conjunctiv
fluid
amniot
fluid
brain
placent
tissu
congenit
infect
fetus
revers
transcriptas
pcr
rtpcr
highli
sensit
specif
known
gold
standard
zikv
diagnosi
regard
zika
virusspecif
rtpcr
sever
convent
realtim
assay
target
prm
e
gene
develop
howev
best
knowledg
food
drug
administr
fda
approv
one
commerci
assay
eg
coba
zika
test
roch
qualit
nucleic
acid
test
screen
zika
viru
rna
blood
donor
addit
fda
author
use
sever
molecular
assay
emerg
use
author
eua
base
rtpcr
triplex
realtim
rtpcr
multiplex
assay
detect
zika
viru
dengu
viru
chikungunya
viru
cdc
zika
viru
rna
qualit
realtim
rtpcr
quest
diagnost
infecti
diseas
inc
realstar
zika
viru
rtpcr
kit
altona
diagnost
gmbh
expect
aptima
zika
viru
assay
base
transcriptionmedi
amplif
tma
technolog
molecular
diagnosi
zika
viru
infect
human
usual
perform
plasma
serum
specimen
within
first
week
onset
clinic
symptom
although
sever
line
evid
advantag
urin
zika
viru
rna
detect
long
durat
viral
shed
easili
collect
specimen
interest
find
indic
shorter
persist
zikv
rna
urin
versu
serum
observ
despit
fact
molecular
diagnosi
possess
high
sensit
specif
short
period
viremia
neg
affect
zika
viru
rna
detect
therefor
detect
antizika
viru
antibodi
serolog
assay
could
advantag
option
wider
diagnost
window
detect
antizika
viru
antibodi
perform
differ
serolog
test
includ
complement
fixat
haemagglutin
inhibit
immunofluoresc
assay
elisa
neutral
test
typic
antizika
viru
igm
antibodi
develop
within
first
week
onset
symptom
detect
day
five
wk
ill
anti
zika
viru
igg
antibodi
rise
day
igm
traceabl
month
year
far
fda
approv
serolog
test
zika
viru
howev
fda
author
use
five
serolog
assay
emerg
use
author
detect
antizika
viru
igm
antibodi
includ
igm
antibodi
captur
elisa
zika
macelisa
cdc
zikv
detect
igm
captur
elisa
inbio
intern
inc
liaison
xl
zika
captur
igm
assay
diasorin
incorpor
advia
centaur
zika
test
siemen
healthcar
diagnost
inc
dpp
zika
igm
system
chembio
diagnost
system
inc
crossreact
flavivirus
dengu
yellow
fever
virus
possibl
nonspecif
reactiv
result
igm
detect
assay
interpret
caution
posit
equivoc
result
must
confirm
plaquereduct
neutral
test
prnt
zika
viru
classifi
risk
group
human
pathogen
therefor
diagnost
laboratori
test
perform
biosafeti
level
facil
viru
inactiv
ultraviolet
uv
radiat
temperatur
solut
ph
ether
potassium
permangan
address
ethic
question
moral
conflict
zika
viru
infect
may
essenti
develop
comprehens
approach
control
public
health
crisi
therefor
health
author
commit
alloc
fair
portion
health
resourc
respond
situat
moral
requir
govern
prioriti
pay
notic
amount
money
prevent
measur
order
control
zika
viru
spread
prioriti
set
usual
difficult
step
encount
situat
especi
absenc
enough
scientif
evid
measur
real
burden
diseas
also
presenc
social
media
pressur
amplifi
olymp
game
brazil
nation
intern
health
author
observ
principl
verac
clear
transpar
inform
system
rais
public
awar
regard
real
situat
intern
level
cosmopolitan
solidar
encount
univers
pattern
diseas
spread
seem
inevit
like
ebola
outbreak
respons
action
requir
respons
intern
bodi
especi
anoth
respons
state
form
global
health
govern
network
mosquito
control
govern
tri
keep
moral
oblig
observ
biosafeti
protect
ecosystem
mind
tri
restrict
insect
spread
reproduct
policymak
diseas
control
delib
ethic
evalu
requir
order
protect
popul
basic
civil
human
right
peopl
free
mobil
reproduct
right
case
border
birth
control
among
solut
similarli
confidenti
patient
health
inform
protect
peopl
stigmat
must
observ
polici
report
probabl
case
health
author
discuss
fear
rais
high
probabl
congenit
problem
mainli
microcephali
neonat
deliv
mother
zika
viru
infect
first
trimest
pregnanc
put
abort
center
moral
concern
posit
variou
school
ethic
regard
abort
rang
strict
prohibit
complet
moral
justif
base
moral
statu
consid
fetu
develop
stage
accordingli
abort
law
still
differ
variou
countri
accord
social
polit
religi
cultur
context
iran
despit
gener
prohibit
abort
crimin
law
therapeut
abort
act
allow
perform
abort
presenc
definit
diagnosi
retard
malform
fetu
unbear
month
wk
concept
attempt
abort
gestat
age
illeg
even
crimin
togeth
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
zika
viru
infect
qualifi
newli
emerg
infecti
diseas
potenti
caus
seriou
public
health
issu
unlik
newli
emerg
infect
lead
sever
morbid
mortal
infect
adult
pediatr
host
zika
infect
pose
signific
threat
infect
adult
risk
due
potenti
caus
fetal
abnorm
provid
infect
occur
pregnanc
inde
among
four
recent
pheic
declar
ie
swine
flu
declar
polio
ebola
declar
zika
viru
declar
zika
uniqu
sens
member
torch
group
infect
ie
group
pathogen
abil
lead
congenit
infectionsanomali
might
influenc
diseas
prevent
manag
strategi
well
rais
ethic
sociolog
issu
thu
increas
awar
medic
commun
togeth
improv
vector
control
diseas
surveil
system
utmost
import
control
potenti
zika
virusrel
threat
differ
countri
ethic
issu
includ
plagiar
inform
consent
misconduct
data
fabric
andor
falsif
doubl
public
andor
submiss
redund
etc
complet
observ
author
